HALO Clinical AI Flyer
Check out our flyer to learn more about HALO Clinical AI Solutions
HALO Clinical AI Flyer Read More »
Lung Macrodissect AI
Clinical Scoring and Validation of a Comprehensive AI-powered Tumour Content and Lung Macrodissection Algorithm
Learn more about Lung Macrodissect AI, an AI-based tool for tumor content quantification and ROI selection guidance.
Lung Macrodissect AI Brochure
Learn more about the automated workflow and benefits of Lung Macrodissect AI.
Lung Macrodissect AI Brochure Read More »
Development & Validation of an AI-based Tumour Cell Estimation Algorithm for Use in a Lung Adenocarcinoma Molecular Pathology Workflow
Learn more about the development and validation of an AI-based molecular pathology algorithm for estimating tumour cells in lung adenocarcinoma.
Looking Back: Reviewing 2024 at Indica Labs
As 2024 draws to a close, we at Indica Labs would like to thank the customers and collaborators who helped fill 2024 with exciting discoveries, events, and partnerships. It is a great honor to have played a part in customers’ contributions to scientific fields ranging from immuno-oncology to infectious disease, immunology, neuroscience, and metabolism.
Looking Back: Reviewing 2024 at Indica Labs Read More »
Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows
Albuquerque, NM – 1 August 2024 – Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.